• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN CLOSUREFAST CATHETER; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN CLOSUREFAST CATHETER; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Stroke/CVA (1770); Thrombosis/Thrombus (4440)
Event Date 10/01/2021
Event Type  Injury  
Event Description
A journal article was submitted presenting a review of the current literature reporting the thrombotic complications associated with current thermal and non-thermal techniques.The article reports related to radiofrequency ablation, clinical events of thrombosis in the superficial vein which can lead to phlebitis, or potentially propagate thrombus formation towards the deep venous system, resulting in a deep vein thrombosis (dvt), and points out these events have potential for pulmonary embolism (pe).The authors report from the review of current literature that initial rates for dvt after rfa treatment were as high as 16%, however more recent literature report lower rates ranging from 0.7-3.4%.A study reviewed which reported 192 patients underwent rfa with a dvt rate of 3.4% at 30-days.The authors report pulmonary embolism as a complication secondary to dvt after rfa is rare and the literature largely consists of case reports but has been reported at a rate of 0.03-0.2%.The article reports that related to the venaseal closure system dvt has also been shown to be a potential complication.The authors report how there can be extension of cyanoacrylate into the deep venous system during the procedure, and it is theorized that this extension of adhesive may induce thrombosis.A cohort study which included 70 patients that underwent venaseal¿ ablation, did not report any serious adverse effects such as dvt or pe.Later studies have shown rates of thrombotic events, ranging from 0-13%.A retrospective review which included 191 patients, reported dvt in 11 patients (5.8%) and another retrospective review of 76 patients reported a dvt rate of 13%.Despite these reports, the largest randomized controlled trial to date, performed comparing rfa and venaseal¿, reported no treatment-associated dvts in 108 patients treated with venaseal¿ within 3-months.This wide range of thrombotic complication rates highlights the need for further large-scale investigation and standardization of follow-up protocol.
 
Manufacturer Narrative
Title: thrombotic complications of superficial endovenous ablation: a contemporary review of thermal and non-thermal techniques author: mariya s.Kochubey, sammy s.Siada, megan tenet journal: the journal of cardiovascular surgery year: 2021 vol/issue: 62(5) ref: 10.23736/s0021-9509.21.11898-1.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLOSUREFAST CATHETER
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCES
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13617376
MDR Text Key290971646
Report Number2183870-2022-00066
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K111887
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-